CNBC's Angelica Peebles talks to Structure Therapeutics CEO Ray Stevens about the obesity landscape and why there's still ...

Get Real-Time News and Alerts for Your Portfolio Leqembi is indicated for Alzheimer’s disease in patients with Mild Cognitive ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

"As anyone who has experienced a cancer diagnosis will know, it takes time to adjust to a new normal," the Princess of Wales ...

New research suggests that the risk for developing dementia is significantly higher than previously estimated, and the burden ...

Researchers found that a type of diabetes medication called sodium-glucose cotransporter-2 (SGLT2) inhibitors may reduce the risk of dementia in older adults with type 2 diabetes. This class of ...

A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...

Dementia risk is nearly 80% higher in stroke survivors than in those without stroke, with risk declining within 1 year but ...

First, a 2015 study from the University of Washington determined that patients who chronically used certain anticholinergic drugs were more likely to develop dementia. The researchers looked at ...